Dr. Harshal Sunil Broker, MD

Dr. Broker practices at Texas Health Care in Fort Worth, Texas.

Dr. Broker's NPI, 1245434034, was assigned on June 13, 2007. Dr. Broker graduated from UT Southwestern Medical Center in 2002. Dr. Broker holds Texas license M3932.

Dr. Broker's primary practice is Texas Health Care, at 1250 8th Ave, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 740-8400.

Dr. Broker's primary practice is Texas Health Care in Fort Worth, Texas. Dr. Broker is also affiliated with Texas Health Fort Worth. The medical group on file is Texas Health Care. Dmand AI also links Dr. Broker to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Broker practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Broker's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Broker is board certified in vascular surgery by the American Board of Surgery. Dr. Broker is licensed in Texas.

Dmand AI lists carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), leg revascularization, peripheral vascular disease, varicose veins and varicose vein treatment among the conditions Dr. Broker treats.

CMS data shows 1,095 Medicare services from Dr. Broker across 18 procedure codes in 2024, for 233 Medicare patients. Medicare paid $1,331,335 for them. Every service was in an office.

CMS counts 233 Medicare patients who saw Dr. Broker in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Broker's median patient age at 73, with 44% women.

In 2024, Dr. Broker wrote 345 Medicare Part D claims for 117 patients. 86% of them were for generic drugs. CMS names the drug for 332 of them, across 5 drugs with 11 or more claims each, at $46,836 in total drug cost. In 2023, CMS named 350 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Broker for performance year 2024, reported through an alternative payment model (APM). Dr. Broker accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 105 procedures of leg revascularization (restoring blood flow) by Dr. Broker, more than 98% of the clinicians it reports for that procedure.

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Broker, published from 2008 to 2018. The most frequent topics are Femoral Vein, Tomography, X-Ray Computed and Ultrasonography, Interventional. Dr. Broker has published most often in J Vasc Surg. Dr. Broker's most frequent co-authors are Frank R. Arko, MD, John Gregory Modrall, MD and Clifford James Buckley, MD.

CMS Open Payments shows 263 general payments to Dr. Broker from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 42% of the total. Volcano Corporation paid the most, $5,073.

Dmand AI lists 2 awards for Dr. Broker, most recently CMS Stage 1 EHR in 2012.

Dr. Broker graduated from UT Southwestern Medical Center in 2002. Dr. Broker is a member of ACS.

Dr. Broker is in network with 21 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.